China is proposing biotech export controls that exempt pharma licensing deals
The draft plan would add five biomedical technologies to Beijing's export-control list and opens a one-month public consultation
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.